Pre-operative evaluation requires baseline coagulation studies, full blood count, and metabolic panel. Patients must adhere to a strict clear liquid diet for 24 hours and undergo mechanical bowel preparation. Anesthesia clearance and consent for potential emergency surgical intervention are mandatory. Prophylactic antibiotics are administered upon induction.
Post-operative care includes immediate monitoring in the PACU. Admission to a surgical ward is mandatory for at least 48 hours. Serial abdominal examinations and monitoring of inflammatory markers are required to rule out peritonitis. Liquid diet is initiated on post-operative day one, progressing to soft diet as tolerated. Discharge is contingent upon stable hemodynamics, absence of fever, and tolerance of oral intake.
Clinical Guide: Endoscopic Full-Thickness Resection (EFTR) – OTSC-Assisted
1. Introduction and Clinical Overview
Endoscopic Full-Thickness Resection (EFTR) represents a paradigm shift in minimally invasive gastroenterology. By allowing for the resection of the entire wall of the gastrointestinal (GI) tract—including the mucosa, submucosa, and muscularis propria—EFTR enables the removal of complex lesions that were previously relegated to surgical intervention.
The Over-the-Scope Clip (OTSC) assisted EFTR technique is currently the gold standard for non-surgical full-thickness resection. By utilizing a specialized nitinol clip, clinicians can achieve secure closure of the resection site before or during the incision, significantly reducing the risk of perforation, peritonitis, and secondary hemorrhage. This procedure is designed for lesions that are difficult to resect via traditional Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD), particularly those with subepithelial involvement or those exhibiting non-lifting signs indicative of fibrosis or deep infiltration.
2. Technical Specifications and Mechanism of Action
The OTSC-assisted EFTR procedure relies on a sophisticated mechanical interplay between the endoscope, a dedicated applicator cap, and a super-elastic nitinol clip.
The Mechanism
- Tissue Apposition: The lesion is drawn into the applicator cap attached to the distal end of the endoscope using an endoscopic grasper or a tissue anchor.
- Clip Deployment: Once the tissue is fully retracted into the cap, the OTSC is deployed. This clip acts as a mechanical suture, sealing the wall layers firmly.
- Resection: With the perforation site pre-sealed by the clip, the clinician utilizes a high-frequency snare or an electrosurgical device to resect the tissue above the clip.
Key Components
| Component | Function |
|---|---|
| OTSC System | A nitinol clip with high closure force, designed to stay in situ. |
| Applicator Cap | Houses the clip and facilitates suction-based or grasper-based tissue retraction. |
| Endoscopic Grasper | Used to pull the target lesion into the cap lumen. |
| Electrosurgical Unit | Provides the current for the resection loop (snare) used to excise the tissue. |
3. Extensive Clinical Indications & Usage
EFTR is indicated for patients who require histological confirmation or curative resection of lesions where standard endoscopic techniques are insufficient.
Primary Indications
- Subepithelial Tumors (SETs): Specifically those originating from the muscularis propria (e.g., GISTs, leiomyomas, or carcinoids).
- Recurrent/Residual Adenomas: Lesions that exhibit significant fibrosis, preventing the "lifting" required for standard EMR.
- Non-lifting Lesions: Cases where prior attempts at ESD have failed due to underlying fibrosis or scarring.
- Difficult-to-reach Dysplasia: Early-stage cancers that require deep tissue margins to ensure R0 (complete) resection.
Clinical Decision Matrix
| Feature | Indication for OTSC-EFTR |
|---|---|
| Lesion Size | Generally < 30mm (to fit within the OTSC cap). |
| Location | Colon, rectum, and stomach (duodenal application is higher risk). |
| Tissue Characteristics | Non-lifting, suspected deep invasion, or subepithelial origin. |
| Patient Status | Medically unfit for open or laparoscopic surgery. |
4. Patient Pre-Operative Preparation
Success in EFTR is heavily dependent on meticulous preparation to ensure a clean visual field and appropriate hemodynamic management.
- Pre-procedural Imaging: EUS (Endoscopic Ultrasound) is mandatory to determine the depth of the lesion and its relationship to surrounding structures (e.g., serosa, adjacent organs).
- Bowel Preparation: For colonic lesions, a high-volume polyethylene glycol (PEG) solution is required to ensure the absence of fecal matter, which could cause post-procedural infection.
- Anticoagulation Management: Clinicians must evaluate the patient’s risk-to-benefit ratio regarding antiplatelet and anticoagulant medication. Ideally, these should be held according to institutional guidelines (typically 3–7 days prior).
- Anesthesia: EFTR is typically performed under deep sedation or general anesthesia with endotracheal intubation, as the procedure involves intentional perforation of the GI wall.
5. The Procedure: Step-by-Step
Phase 1: Access and Marking
The endoscope is advanced to the site. If the lesion margins are not clear, tattoos are placed 5mm distal and proximal to the lesion.
Phase 2: Anchoring and Suction
The endoscopic grasper is passed through the working channel. The grasper engages the center of the lesion, pulling it into the applicator cap. The clinician must verify that the surrounding healthy mucosa is also drawn into the cap to ensure a "full-thickness" capture.
Phase 3: Deployment
The OTSC is released. The nitinol clip snaps shut, creating a "pseudopolyp" of tissue that includes all layers of the wall. This effectively seals the potential perforation site.
Phase 4: Resection
A specialized snare is placed around the pseudopolyp. Using electrosurgical cutting current (EndoCut Q or similar settings), the tissue is excised. The specimen is then retrieved for histopathological analysis.
Phase 5: Inspection
The site is inspected for secondary bleeding. If bleeding occurs, additional clips or thermal coagulation may be applied.
6. Post-Operative Recovery Protocol
The recovery phase is critical to identifying early complications like delayed perforation or hemorrhage.
- Observation: Patients are typically monitored in a recovery unit for 4–6 hours post-procedure.
- Dietary Advancement: A clear liquid diet is initiated 6–12 hours post-procedure, transitioning to a soft diet within 24 hours if no signs of peritonitis are present.
- Pain Management: Mild abdominal discomfort is common. Significant, increasing pain, fever, or tachycardia necessitates an immediate CT scan with oral contrast to rule out micro-perforation.
- Follow-up: A follow-up colonoscopy or endoscopy is usually scheduled 3–6 months later to verify the integrity of the wall and ensure no recurrence.
7. Risks, Side Effects, and Contraindications
While EFTR is minimally invasive, it is not without risk.
Potential Complications
- Perforation: While the OTSC is designed to seal the defect, incomplete capture of the wall layers can lead to a residual leak.
- Bleeding: Intra-procedural bleeding is managed during the procedure; however, delayed bleeding can occur 3–7 days post-procedure.
- Infection: Risk of peritonitis if the seal is compromised.
- Clip Migration: The OTSC may eventually detach and pass through the digestive tract. This is a normal occurrence, but patients should be warned of it.
Contraindications
- Severe Comorbidities: Patients with severe cardio-pulmonary instability who cannot tolerate general anesthesia.
- Large Lesions: Lesions > 30mm often cannot be captured by the standard OTSC cap.
- Adhesions: Significant intra-abdominal adhesions from prior surgeries may increase the risk of injury to adjacent organs during the suction phase.
8. Alternative Treatments
| Treatment | When to Choose |
|---|---|
| Laparoscopic Surgery | For lesions > 30mm or suspected malignancy requiring lymph node dissection. |
| ESD (Endoscopic Submucosal Dissection) | For superficial lesions where the submucosal plane is intact. |
| EMR (Endoscopic Mucosal Resection) | For benign, small, pedunculated polyps. |
| Watchful Waiting | For very small, low-risk subepithelial tumors (e.g., small lipomas). |
9. Frequently Asked Questions (FAQ)
Q1: How long does the OTSC stay in the body?
A: The OTSC usually stays in place for several weeks to months before detaching naturally. It then passes through the stool.
Q2: Is EFTR painful?
A: The procedure is performed under sedation, so the patient feels nothing. Post-procedure, some mild abdominal cramping is common, which is managed with standard analgesics.
Q3: Is a hospital stay required?
A: Most patients are discharged the same day or the following morning, depending on the site of the procedure and institutional protocols.
Q4: What happens if the OTSC doesn't seal the hole completely?
A: If a leak is suspected, the endoscopist will apply additional clips or a suture to close the defect. In rare cases, emergency surgical intervention may be required.
Q5: Can EFTR treat cancer?
A: EFTR is highly effective for early-stage GI cancers (T1 stage). It is not suitable for advanced cancers that have spread to the lymph nodes.
Q6: What is the success rate of R0 resection?
A: Studies indicate an R0 (complete) resection rate of approximately 85–95% for appropriately selected lesions.
Q7: Can I eat immediately after the procedure?
A: No. Patients are typically kept NPO (nothing by mouth) for several hours to allow for the initial healing of the clip site.
Q8: Are there long-term side effects?
A: Long-term side effects are rare. The site of resection typically heals with a small scar.
Q9: Does the OTSC interfere with future MRIs?
A: The OTSC is made of nitinol. It is generally considered MRI-safe, but always inform your radiologist if you have a metallic clip in your GI tract.
Q10: Who is the ideal candidate for EFTR?
A: The ideal candidate is a patient with a small (under 30mm) subepithelial lesion or a fibrotic, non-lifting lesion who is at higher risk for surgery.
10. Conclusion
EFTR, assisted by the OTSC system, is a revolutionary technique that bridges the gap between traditional endoscopy and invasive surgery. By providing a safe, controlled method for full-thickness wall resection, it offers patients a curative option with significantly reduced morbidity compared to surgical resection. As technology advances, the indications for this procedure are likely to expand, further cementing its role in the gastroenterologist's armamentarium.
Disclaimer: This guide is intended for educational purposes for medical professionals. Always follow your institution’s specific clinical protocols and manufacturer guidelines for the OTSC system.
